Our story
- About us
- Latest
- Centres
Our science
- Mission
  - Discover
  - Develop
  - Deliver
- Approaches
- Explore by
Our people
- Researchers
- Governance
- Latest
  
  Sep 10, 2024 - Update
  
  Shaping the future of dementia research: Meet the UK DRI’s newest Emerging Leaders
  
  We are pleased to announce three new UK DRI Emerging Leaders: Dr Maura Malpetti, Dr...
  Learn more Shaping the future of dementia research: Meet the UK DRI’s newest Emerging Leaders
Our partners
- Partnerships
- Initiatives
  - Dementia Trials Accelerator (DTA)
  - CURE-ND
- Latest
  
  Jan 01, 2024 - Feature
  
  Why partner with the UK DRI?
  
  The UK DRI is central to a rich and connected dementia research ecosystem, and we...
  Learn more Why partner with the UK DRI?
Careers
- Join us
  - Vacancies
  - Centres
- Latest
  
  Jan 01, 2024 - Feature
  
  Why join the UK DRI?
  
  By joining the UK DRI you’ll belong to a team of world-class researchers, technical specialists...
  Learn more Why join the UK DRI?
Public Information
- Information
- Dementias
- Movement conditions

Alzheimers Dement

Published Jan 01, 1970

Cortical tau is associated with microstructural imaging biomarkers of neurite density and dendritic complexity in Alzheimer's disease.

Authors

Philip S J Weston, William Coath, Matthew J Harris, Ian B Malone, John Dickson, Franklin I Aigbirhio, David M Cash, Hui Zhang, Jonathan M Schott

Read More

Abstract

In Alzheimer's disease (AD), hyperphosphorylated tau is closely associated with focal neurodegeneration, but the mechanism remains uncertain.

PMID:36932979 | DOI: